Bausch + Lomb Announces New Scientific Data and Analyses Featuring Consumer, Vision Care and Pharmaceuticals Will Be Presented During Optometry's Meeting

Bausch + Lomb announced that researchers will present the results of 11 scientific poster presentations involving the company’s consumer, vision care and pharmaceutical products during the American Optometric Association (AOA) Optometry’s Meeting e-posters virtual event, which is taking place from June 13-14, 2023. In addition, the company will host several sponsored education events at the Optometry’s Meeting in Washington, D.C. from June 21-24, 2023.

The poster presentations will include data from the two pivotal phase 3 trials, GOBI and MOJAVE, and 12-month KALAHARI safety extension study of Miebo (perfluorohexyloctane ophthalmic solution). Miebo was approved by the FDA on May 18, 2023, for the treatment of the signs and symptoms of dry eye disease (DED). It is the first and only FDA approved prescription eye drop that directly targets tear evaporation in individuals with DED, according to B+L. Three posters will highlight the benefits of new Biotrue Hydration Boost Contact Lens Rehydrating Drops, and two others will feature new data on our recently launched Bausch + Lomb Infuse Multifocal silicone hydrogel (SiHy) daily disposable contact lenses designed for presbyopic patients: a comparison of the power profiles across the near, intermediate and distance vision zones and an eye care practitioner fitting assessment of the lens.

“Bausch + Lomb is committed to investing in, and bringing to market, new innovations that help eye care practitioners meet the evolving vision needs of their patients,” said Yehia Hashad, MD, executive vice president, Research & Development and chief medical officer, Bausch + Lomb. “We will share some of these new innovations, including Miebo, Biotrue Hydration Boost for Contacts and Bausch + Lomb Infuse Multifocal lenses, with attendees during the Optometry’s Meeting. We also look forward to presenting a variety of new data on these products and some of our other consumer and pharmaceutical products, as well as hosting attendees at our education events.”

The complete list of scientific e-poster presentations, as well as details for the featured education events, is as follows:

E-Poster Presentations

• “A New Preservative-free Lubricating and Rewetting drop with Antioxidant Erythritol Protects Hyaluronan (HA) from Free Radicals.” Siverling et al.
• “Clinical Evaluation of the Safety and Tolerability of Lumify Eye Illuminations (LEI) Cosmetic Products.” Wesley et al.
• “Clinical Performance of Unique Preservative Free Contact Lens Lubricating and Rewetting Drop.” Shafer et al.
• “Contemporary Progressive Daily Disposable Silicone Hydrogel Multifocal Contact Lenses: A Comparison of Power Profiles Across Near, Intermediate and Distance Zones.” Reindel et al.
• “Cumulative Irritation Testing and Repeated Insult Patch Testing with Lumify Eye Illuminations (LEI) Cosmetic Products.” Wesley et al.
• “Hyaluronan (HA) from a new preservative-free lubricating and rewetting drop is retained and released by conventional and silicone hydrogel contact lenses.” Scheuer et al.
• “Latanoprostene bunod 0.024% in patients switched from prior pharmacotherapy: a multicenter retrospective chart review.” Cothran et al.
• “Long-term Safety and Efficacy of NOV03 (Perfluorohexyloctane) for the Treatment of Patients with Dry Eye Disease Associated with Meibomian Gland Dysfunction: the KALAHARI Study.” Evans et al.
• “Perfluorohexyloctane (NOV03) for Dry Eye Disease Associated with Meibomian Gland Dysfunction: In Vitro Inhibition of Evaporation.” Vollmer et al.
• “Perfluorohexyloctane (NOV03) for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Pooled Analysis of GOBI and MOJAVE Studies.” Fahmy et al.
• “Practitioner Assessment of Fitting a Novel Silicone Hydrogel Daily Disposable Multifocal Contact Lens.” Rah et al.

Featured Education Events

Wednesday, June 21

• “Showcasing Inflammation and IOP Control”
  7:00 p.m. ET at Del Frisco’s (950 St. NW, Suite 501, Washington, DC)
  Derek Cunningham, O.D., and Justin Schweitzer, O.D., will discuss the benefits of using LOTEMAX SM (loteprednol etabonate ophthalmic gel), 0.38%, and VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%. Register in advance at https://na.eventscloud.com/website/54916/.

Thursday, June 22

• “Eyeing Up Evaporation: Getting at the Heart of Dry Eye Disease”
  8:00-9:00 a.m. ET in Room #207B (level 2) in the Walter E. Washington Convention Center
  Jade Coats, O.D., and James Deom, O.D., will discuss current thinking on the role of evaporation in DED, reviewing causative factors, DED pathophysiology, diagnostic approaches and current treatments.

• “Believe in the Power of Multifocals: Introducing Bausch + Lomb INFUSE Multifocal”
  12:00-1:00 p.m. ET in Room #207B (level 2) in the Walter E. Washington Convention Center
  Mile Brujic, O.D., and Paul Karpecki, O.D., will lead a conversation on the new Bausch + Lomb INFUSE Multifocal contact lenses, which were designed to directly address the common problems that presbyopic patients experience with multifocal lenses, including contact lens dryness.

• “All Eyes on Evaporation”
  7:00 p.m. ET at Mastro’s Steakhouse (600 13th St NW, Washington, DC)
  Melissa Barnett, O.D., and Paul Karpecki, O.D., will discuss current thinking on the role of evaporation in DED. Reviewing causative factors, DED pathophysiology diagnostic approaches and current treatments. Register in advance: https://na.eventscloud.com/website/54915/.

Friday, June 23

• “Showcasing Inflammation and IOP Control”
  8:00-9:00 a.m. ET in Room #207A (level 2) in the Walter E. Washington Convention Center
  Nora Cothran, O.D., and Jessica Steen, O.D., will discuss two of the company's pharmaceutical advancements: LOTEMAX® SM (loteprednol etabonate ophthalmic gel), 0.38%, and VYZULTA (latanoprostene bunod ophthalmic solution), 0.024%.

• “Bausch + Lomb Practice Pearls & Innovative Products”
  12:00-1:00 p.m. ET in Room #207A (level 2) in the Walter E. Washington Convention Center
  Ben Gaddie, O.D., and Mile Brujic, O.D., FAAO will share practical patient cases using products from across the Bausch + Lomb consumer, vision care and pharmaceutical portfolios.